Financial Services Related News

Why M Ventures is Investing in Synthetic Biology Companies – Meet Andreas Jurgeit

This week we interviewed someone who is passionate about startups that are transforming innovative ideas into commercial success with real-world benefits, as well as new ideas around life science technologies. Andreas Jurgeit, Investment Director of the Life Science team at [...]

By | September 16th, 2017|Financial Services, Industry Support, News|

Sean O’Sullivan at IndieBio’s 5th Demo Day

Every single one of us on this stage is touched by the challenges that we all face in life sciences. Which is why with IndieBio we aim to tackle all these really challenging and incredibly important issues not just [...]

Bioeconomy Fund 1 completes $8.3M of investments in six companies that are building critical infrastructure for the 21st century global economy.

SEATTLE, Washington – Sep 13, 2017 – Bioeconomy Capital announces that Fund 1 is fully invested. Fund 1 portfolio companies exemplify the breadth and impact of biological technologies on consumers, businesses, and markets. Bioeconomy Capital engages at an early [...]

By | September 14th, 2017|Financial Services, Industry Support, News, Press Releases|

Show Me the Money: 5 Biotech-Ready VCs

Investing in biotech is like eating your greens and waking up at 6 in the morning to go to the gym. Everyone knows it’s the way to go, and yet most don’t actually do it. Biotech has rapidly gained more [...]

By | June 5th, 2017|Financial Services, Industry Support, News|

Data Collective Partners with Dr. John Cumbers, Founder of SynBioBeta, to Launch Pre-Seed and Seed Stage Synthetic Biology Venture Fund

Palo Alto, CA, April 4, 2017 - Data Collective (DCVC), a venture capital fund investing in entrepreneurs applying deep tech to transform giant industries, today announced it is partnering with Dr. John Cumbers to launch a pre-seed and seed venture [...]

By | April 4th, 2017|Financial Services, Industry Support, News, Press Releases|

Sofinnova Partners Raises €106 Million in a First Closing of Its Industrial Biotech Fund

PARIS--(BUSINESS WIRE)--Sofinnova Partners, a leading European venture capital firm specialized in life sciences, today announced the first closing of Sofinnova Industrial Biotech I (Sofinnova IB I) at €106 million. The fund, dedicated to renewable chemistry, follows a series of 9 investments [...]

By | March 2nd, 2017|Financial Services, Industry Support, News, Press Releases|